ABIONYX (formerly CERENIS Therapeutics) is a  biotech company dedicated to the discovery and development of therapies for patients. It provides programs for the treatment of cardiovascular diseases and associated metabolic diseases such as NAFLD and NASH as well as a HDL targeted drug delivery platform in oncology, specifically in immuno-oncology and chemotherapy